Search

Jiancun L Zhang

from Oakland, CA
Age ~60
Get Report
Also known as:
Jiancun Cen Hui Zhang, Jiancun Z Zhang, Jiandi Zhang, Jian Zhang, Larry Zhang Jiancun, Jian Z Wang
Phone and address:
5142 Masonic Ave, Oakland, CA 94618
Related to:
Wang D ZhangCen Hui, 60Zhuo Chen, 55Shulong Cen, 98Cindy L Cen, 67Jian G Gao, 56Jingyi Wang, 34Christopher S Hmelar, 38Ban WangXinnian Wang, 62Jianan Chen, 28Yaoqi Q Chen, 67Clay L Zhang, 55Zhuo Chen, 56Stephen L Hmelar, 68Diane Y Bai, 49Jiannan ChenHui Z Cen, 65
Connected to:
Aimei Zhang, 44Aining Zhang, 30Aiqing Zhang, 50Alexia Y Zhang, 36Amy X Zhang, 57Angelina Zhang, 54Ashley C Zhang, 60Baomin Zhang, 55Beilei Zhang, 45Carl Zhang, 33

Jiancun Zhang Phones & Addresses

  • 5142 Masonic Ave, Oakland, CA 94618
  • Berkeley, CA
  • Hercules, CA
  • Palo Alto, CA
  • San Francisco, CA
  • Coppell, TX
  • Foster City, CA
  • Durham, NC
  • 2187 35Th Ave, San Francisco, CA 94116 (415) 245-2432

Work

Company: Gibh Position: Director of chemistry

Education

Degree: High school graduate or higher

Skills

Chemistry

Industries

Biotechnology

Resumes

Resumes

Jiancun Zhang Photo 1

Director Of Chemistry

View page
Location:
Berkeley, CA
Industry:
Biotechnology
Work:
GIBH
Director of Chemistry
Skills:
Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jiancun Zhang
EPOCH INVESTMENT LLC

Publications

Us Patents

Cellular Accumulation Of Phosphonate Analogs Of Hiv Protease Inhibitor Compounds

View page
US Patent:
7649015, Jan 19, 2010
Filed:
Apr 25, 2003
Appl. No.:
10/423496
Inventors:
Xiaowu Chen - San Mateo CA, US
Maria Fardis - San Carlos CA, US
Gong-Xin He - Fremont CA, US
Haolun Jin - Foster City CA, US
Choung U. Kim - San Carlos CA, US
William A. Lee - Los Altos CA, US
Kuei-Ying Lin - Fremont CA, US
Hongtao Liu - Foster City CA, US
Richard L. Mackman - Millbrae CA, US
Michael L. Mitchell - Foster City CA, US
Hyung-Jung Pyun - Fremont CA, US
Mark Sparacino - Morgan Hill CA, US
Sundaramoorthi Swaminathan - Burlingame CA, US
Jianying Wang - Foster City CA, US
Matthew A. Williams - San Mateo CA, US
Lianhong Xu - San Mateo CA, US
Zheng-Yu Yang - Foster City CA, US
Richard H. Yu - San Francisco CA, US
Jiancun Zhang - Oakland CA, US
Lijun Zhang - Foster City CA, US
Assignee:
Gilead Sciences, Inc. - Palo Alto CA
International Classification:
A61K 31/343
C07F 9/28
US Classification:
514470, 549220
Abstract:
Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.

Method And Compositions For Identifying Anti-Hiv Therapeutic Compounds

View page
US Patent:
20050239054, Oct 27, 2005
Filed:
Dec 22, 2003
Appl. No.:
10/740694
Inventors:
Murty Arimilli - Oakridge NC, US
Mark Becker - Redwood City CA, US
Gabriel Birkus - Foster City CA, US
Clifford Bryant - Millbrae CA, US
James Chen - San Ramon CA, US
Xiaowu Chen - San Mateo CA, US
Tomas Cihlar - Foster City CA, US
Azar Dastgah - San Mateo CA, US
Eugene Eisenberg - San Carlos CA, US
Maria Fardis - San Carlos CA, US
Marcos Hatada - Fremont CA, US
Gong-Xin He - Fremont CA, US
Haolun Jin - Foster City CA, US
Choung Kim - San Carlos CA, US
William Lee - Los Altos CA, US
Christopher Lee - San Francisco CA, US
Kuei-Ying Lin - Fremont CA, US
Hongtao Liu - Cupertino CA, US
Richard MacKman - Millbrae CA, US
Martin McDermott - Redwood City CA, US
Michael Mitchell - Foster City CA, US
Peter Nelson - Los Altos CA, US
Hyung-Jung Pyun - Fremont CA, US
Tanisha Rowe - Modesto CA, US
Mark Sparacino - Morgan Hill CA, US
Sundaramoorthi Swaminathan - Burlingame CA, US
James Tario - San Mateo CA, US
Jianying Wang - Foster City CA, US
Matthew Williams - San Mateo CA, US
Lianhong Xu - San Mateo CA, US
Zheng-Yu Yang - Foster City CA, US
Richard Yu - San Francisco CA, US
Jiancun Zhang - Oakland CA, US
Lijun Zhang - Palo Alto CA, US
International Classification:
C12Q001/70
A61K031/675
A61K031/66
US Classification:
435005000, 514114000, 514080000
Abstract:
Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.

Cellular Accumulation Of Phosphonate Analogs Of Hiv Protease Inhibitor Compounds

View page
US Patent:
20070010489, Jan 11, 2007
Filed:
Apr 25, 2003
Appl. No.:
10/511998
Inventors:
Murty Arimilli - Oak Ridge NC, US
Mark Becker - Redwood City CA, US
Clifford Bryant - Millbrae CA, US
James Chen - San Ramon CA, US
Xiaowu Chen - San Mateo CA, US
Azar Dastgah - San Mateo CA, US
Maria Fardis - San Carlos CA, US
Gong-Xin He - Fremont CA, US
Haolun Jin - Foster City CA, US
Choung Kim - San Carlos CA, US
William Lee - Los Altos CA, US
Christopher Lee - San Francisco CA, US
Kuei-Ying Lin - Fremont CA, US
Hongtao Liu - Cupertino CA, US
Richard Mackman - Millbrae CA, US
Michael Mitchell - Hayward CA, US
Peter Nelson - Los Altos CA, US
Hyung-Jung Pyun - Fremont CA, US
Tanisha Rowe - Modesto CA, US
Mark Sparacino - Morgan Hill CA, US
Sundaramoorthi Swaminathan - Burlingame CA, US
James Tario - San Mateo CA, US
Jianying Wang - Foster City CA, US
Matthew Wiliams - San Mateos CA, US
Lianhong Xu - San Mateo CA, US
Zheng-Yu Yang - Foster City CA, US
Richard Yu - San Francisco CA, US
Jiancun Zhang - Oakland CA, US
Lijun Zhang - Palo Alto CA, US
International Classification:
A61K 31/663
C07F 9/6515
C07F 9/6512
US Classification:
514079000, 514114000, 514085000, 540542000, 544243000, 558190000, 549005000
Abstract:
Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.

Method For Oligonucleotide Analog Synthesis

View page
US Patent:
56462697, Jul 8, 1997
Filed:
Apr 28, 1994
Appl. No.:
8/234452
Inventors:
Mark D. Matteucci - Burlingame CA
Jiancun Zhang - San Francisco CA
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07H 1906
C07H 1916
US Classification:
536 267
Abstract:
The present invention is directed to improved methods to synthesize oligonucleotide analogs having an acetal linkage, such as a 3',5'-formacetal (3' --O--CH. sub. 2 --O-- 5'), 3',5'-thioformacetal (3' --S--CH. sub. 2 --O-- 5') or an analogous 2',5' linkage between adjacent nucleoside analog residues. Compositions comprising 5', 3' and 2' phosphinate nucleoside analogs useful in the methods are also provided.

Method For Preparing Pyrimidone Compound

View page
US Patent:
20200157054, May 21, 2020
Filed:
Jul 3, 2018
Appl. No.:
16/627966
Inventors:
- Hong Kong, CN
Xiaojun WANG - Dongguan, CN
Jihua LIN - Dongguan, CN
Liang CHEN - Dongguan, CN
Yingjun ZHANG - Dongguan, CN
Jiancun ZHANG - San Mateo CA, US
Assignee:
NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED - Hong Kong
International Classification:
C07D 239/36
C07C 211/50
Abstract:
A method for preparing a pyrimidone compound and an important intermediate in which raw materials of the preparation method are cheap, the reaction condition of preparation method is mild, the preparation method is simple to operate, and is safe and controllable, has high total yield, and thus is suitable for industrial production.

Fused Ring Compounds As Hepatitis C Virus Inhibitors, Pharmaceutical Compositions And Uses Thereof

View page
US Patent:
20150307509, Oct 29, 2015
Filed:
Nov 28, 2013
Appl. No.:
14/647449
Inventors:
- Dongguan, Guangdong, CN
Jiancun ZHANG - San Mateo CA, US
Hongming XIE - DONGGUAN, CN
Qingyun REN - DONGGUAN, CN
Shifeng LI - DONGGUAN, CN
Changping FU - DONGGUAN, CN
Bailin HU - DONGGUAN, CN
Xiwei WU - DONGGUAN, CN
Changhua TANG - DONGGUAN, CN
Assignee:
SUNSHINE LAKE PHARMA CO., LTD. - Dongguan, Guangdong
International Classification:
C07D 491/107
A61K 31/4178
C07D 471/08
A61K 31/439
A61K 45/06
A61K 31/438
C07D 401/14
A61K 31/454
A61K 31/517
A61K 31/4709
C07D 403/14
A61K 31/4184
Abstract:
Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X′, Y, Y′, A, A′, Q, Q, R-R, X, R, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.

Spiro Compounds As Hepatitis C Virus Inhibitors

View page
US Patent:
20140147412, May 29, 2014
Filed:
Jul 9, 2012
Appl. No.:
14/130320
Inventors:
Jiancun Zhang - San Mateo CA, US
Yingjun Zhang - Dongguan, CN
Hongming Xie - Dongguan, CN
Qingyun Ren - Dongguan, CN
Huichao Luo - Dongguan, CN
Tianzhu Yu - Dongguan, CN
Yumei Tan - Dongguan, CN
Assignee:
SUNSHINE LAKE PHARMA CO., LTD. - Dongguan, Guangdong
International Classification:
C07K 5/062
A61K 45/06
A61K 38/05
US Classification:
424 852, 5483011, 544 70, 546 15, 546 17, 514 43, 548147, 548409, 424 857, 424 855
Abstract:
Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.
Control profile
Jiancun L Zhang from Oakland, CA, age ~60 Get Report